Data Visualization7 min readUpdated 2026-04-03

    GLP-1 Dosing Visual Guide: Titration Schedules for Semaglutide, Tirzepatide, and Retatrutide

    Visual step-by-step dosing guide showing titration schedules, dose escalation timelines, and what to expect at each dose level for all GLP-1 medications.

    Dosing Principle

    Start low, go slow. Gradual dose titration over 4-5 months minimizes side effects while building to therapeutic levels. Your Trimi provider guides each step.

    Semaglutide Titration ($99/mo)

    0.25mgWeeks 1-4IntroductionMinimal side effects expected. Body adjusting.
    0.5mgWeeks 5-8BuildingAppetite reduction begins. Mild nausea possible.
    1.0mgWeeks 9-12TherapeuticSignificant appetite suppression. Weight loss accelerating.
    1.7mgWeeks 13-16EnhancedStrong efficacy. May stay here if well-tolerated.
    2.4mgWeek 17+MaximumFull therapeutic dose. Maximum weight loss potential.

    Tirzepatide Titration ($125/mo)

    2.5mgWeeks 1-4IntroductionLow side effect risk. Body adjusting.
    5.0mgWeeks 5-8BuildingAppetite reduction noticeable. First meaningful dose.
    7.5mgWeeks 9-12IntermediateGood balance of efficacy and tolerability.
    10mgWeeks 13-16TherapeuticStrong weight loss. Many patients stay here.
    12.5mgWeeks 17-20EnhancedNear-maximum efficacy.
    15mgWeek 21+MaximumFull therapeutic dose. Highest weight loss.

    Titration Tips

    Best Practices

    • Stay at each dose for minimum 4 weeks
    • Inject on the same day each week
    • Increase dose only when side effects resolve
    • Track side effects at each dose level

    When to Pause

    • Persistent vomiting at current dose
    • Unable to maintain adequate hydration
    • Severe abdominal pain
    • Contact your Trimi provider before any dose change

    Medical Disclaimer: Dosing schedules should be individualized by your healthcare provider. Never change your dose without provider guidance.

    Frequently Asked Questions

    How does GLP-1 dose titration work?

    All GLP-1 medications start at a low dose and gradually increase over weeks to months. This slow titration minimizes side effects by allowing your body to adjust. Semaglutide typically titrates from 0.25mg to 2.4mg over 16-20 weeks. Tirzepatide goes from 2.5mg to 15mg over 20-28 weeks.

    Can I increase my dose faster?

    Faster titration increases the likelihood and severity of side effects, especially nausea and vomiting. The standard schedule is designed for optimal tolerability. Only increase doses under provider guidance, and never faster than the recommended schedule.

    What if I cannot tolerate a dose increase?

    Stay at your current dose for an additional 2-4 weeks. If side effects persist, your provider may reduce the dose temporarily. Many patients find they can eventually tolerate higher doses after a longer adjustment period. Not everyone needs the maximum dose.

    Do I need to reach the maximum dose?

    No. The right dose is the one that produces adequate weight loss with tolerable side effects. Some patients achieve their goals at moderate doses. Your Trimi provider will work with you to find your optimal dose, which may not be the maximum.

    Expert-Guided Dosing

    Compounded semaglutide from $99/mo or tirzepatide from $125/mo.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What should patients know about GLP-1 dose titration and administration?

    Cited sources below cover the regulatory and clinical context for GLP-1 dose titration and administration. Trimi's clinical-review process — coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network — addresses GLP-1 dose titration and administration as part of the individualized patient-care plan. Compounded medications are dispensed by 503A community sterile compounding pharmacies (VialsRx, GreenwichRx). This is general information based on the cited sources, not medical advice.

    Key Takeaways

    • FDA labeling specifies a dose-titration schedule for each GLP-1 medication, increasing in 4-week increments to improve tolerability. The titration schedule is not a recommendation — skipping or accelerating titration is associated with higher adverse-event rates.
    • GLP-1 receptor agonists require a prescription. Eligibility is determined by a licensed clinician based on BMI, weight-related comorbidities, and screening for contraindications (medullary thyroid carcinoma history, MEN 2, pancreatitis history, severe GI / renal disease, pregnancy, breastfeeding).
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 17, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook
    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) Prescribing Information — Dosage and Administration. FDA.Read Study
    2. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information — Dosage and Administration. FDA.Read Study
    3. U.S. Food and Drug Administration (2024). Mounjaro (tirzepatide) Prescribing Information — Dosage and Administration. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Visual timeline showing what to expect each week and month on GLP-1 medications. Weight loss milestones, side effect patterns, and body changes mapped out.

    Visual comparison of side effect rates across all GLP-1 medications. Data-driven chart showing nausea, vomiting, diarrhea, and other side effects by medication and dose.

    Visual infographic showing how semaglutide, tirzepatide, and retatrutide affect every body system -- brain, heart, liver, gut, pancreas, and more.

    Side-by-side comparison of retatrutide, tirzepatide, and semaglutide: mechanisms, weight loss data, side effects, dosing, cost, and availability in 2026.

    Start your GLP-1 journey — from $99/mo

    Get Started